Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Clinical Characteristics in Patients with Triple Negative Breast Cancer.

Yeh J, Chun J, Schwartz S, Wang A, Kern E, Guth AA, Axelrod D, Shapiro R, Schnabel F.

Int J Breast Cancer. 2017;2017:1796145. doi: 10.1155/2017/1796145. Epub 2017 Aug 17.

2.

The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer.

Guth AA, Chun Kim J, Schwartz S, Montes J, Snyder RA, Axelrod D, Schnabel F.

Breast J. 2017 Mar;23(2):177-181. doi: 10.1111/tbj.12781.

PMID:
28299888
3.

Usability and feasibility of health IT interventions to enhance Self-Care for Lymphedema Symptom Management in breast cancer survivors.

Fu MR, Axelrod D, Guth AA, Wang Y, Scagliola J, Hiotis K, Rampertaap K, El-Shammaa N.

Internet Interv. 2016 Sep;5:56-64. doi: 10.1016/j.invent.2016.08.001. Epub 2016 Aug 4.

4.

Breast Cancer Profile among Patients with a History of Chemoprevention.

Schnabel FR, Pivo S, Chun J, Schwartz S, Refinetti AP, Axelrod D, Guth A.

Int J Breast Cancer. 2016;2016:9216375. doi: 10.1155/2016/9216375. Epub 2016 Dec 18.

5.

mHealth self-care interventions: managing symptoms following breast cancer treatment.

Fu MR, Axelrod D, Guth AA, Rampertaap K, El-Shammaa N, Hiotis K, Scagliola J, Yu G, Wang Y.

Mhealth. 2016 Jul;2. pii: 28. Epub 2016 Jul 22.

6.

Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction.

Fu MR, Conley YP, Axelrod D, Guth AA, Yu G, Fletcher J, Zagzag D.

Breast. 2016 Oct;29:231-40. doi: 10.1016/j.breast.2016.06.023. Epub 2016 Jul 22.

PMID:
27460425
7.

A Web- and Mobile-Based Intervention for Women Treated for Breast Cancer to Manage Chronic Pain and Symptoms Related to Lymphedema: Randomized Clinical Trial Rationale and Protocol.

Fu MR, Axelrod D, Guth A, Scagliola J, Rampertaap K, El-Shammaa N, Fletcher J, Zhang Y, Qiu JM, Schnabel F, Hiotis K, Wang Y, D'Eramo Melkus G.

JMIR Res Protoc. 2016 Jan 21;5(1):e7. doi: 10.2196/resprot.5104.

8.

Oncologic outcomes after nipple-sparing mastectomy: A single-institution experience.

Frey JD, Alperovich M, Kim JC, Axelrod DM, Shapiro RL, Choi M, Schnabel FR, Karp NS, Guth AA.

J Surg Oncol. 2016 Jan;113(1):8-11. doi: 10.1002/jso.24097. Epub 2015 Dec 2.

PMID:
26628318
9.

Symptom report in detecting breast cancer-related lymphedema.

Fu MR, Axelrod D, Cleland CM, Qiu Z, Guth AA, Kleinman R, Scagliola J, Haber J.

Breast Cancer (Dove Med Press). 2015 Oct 15;7:345-52. doi: 10.2147/BCTT.S87854. eCollection 2015.

10.

Nipple-sparing Mastectomy and Sub-areolar Biopsy: To Freeze or not to Freeze? Evaluating the Role of Sub-areolar Intraoperative Frozen Section.

Alperovich M, Choi M, Karp NS, Singh B, Ayo D, Frey JD, Roses DF, Schnabel FR, Axelrod DM, Shapiro RL, Guth AA.

Breast J. 2016 Jan-Feb;22(1):18-23. doi: 10.1111/tbj.12517. Epub 2015 Oct 28.

PMID:
26510917
11.

Cost Analysis of Intraoperative Subareolar Frozen Section During Nipple-Sparing Mastectomy.

Alperovich M, Reis SM, Choi M, Karp NS, Frey JD, Chang JB, Axelrod DM, Shapiro RL, Guth AA.

Ann Surg Oncol. 2016 Feb;23(2):490-3. doi: 10.1245/s10434-015-4882-8. Epub 2015 Oct 5.

PMID:
26438436
12.

Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study.

Fu MR, Axelrod D, Guth AA, Fletcher J, Qiu JM, Scagliola J, Kleinman R, Ryan CE, Chan N, Haber J.

J Pers Med. 2015 Sep 3;5(3):326-40. doi: 10.3390/jpm5030326.

13.

Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions.

Valeta-Magara A, Hatami R, Axelrod D, Roses DF, Guth A, Formenti SC, Schneider RJ.

Springerplus. 2015 Sep 5;4:483. doi: 10.1186/s40064-015-1260-8. eCollection 2015.

14.

Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective Study.

Fu MR, Axelrod D, Guth AA, Cleland CM, Ryan CE, Weaver KR, Qiu JM, Kleinman R, Scagliola J, Palamar JJ, Melkus GD.

J Pers Med. 2015 Jun 26;5(3):229-42. doi: 10.3390/jpm5030229.

15.

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.

Singh B, Smith JA, Axelrod DM, Ameri P, Levitt H, Danoff A, Lesser M, de Angelis C, Illa-Bochaca I, Lubitz S, Huberman D, Darvishian F, Kleinberg DL.

Breast Cancer Res. 2014 Nov 11;16(6):463. doi: 10.1186/s13058-014-0463-1.

16.

Clinical trial evidence of the antitumor activity of topical imiquimod for breast cancer skin metastases.

Adams S, Novik Y, Oratz R, Axelrod D, Speyer J, Tiersten A, Goldberg JD, Bhardwaj N, Unutmaz D, Demaria S, Formenti S.

J Clin Oncol. 2014 Oct 1;32(28):3204-5. doi: 10.1200/JCO.2014.56.1282. Epub 2014 Aug 4. No abstract available.

PMID:
25092780
17.

Nipple-sparing mastectomy in patients with prior breast irradiation: are patients at higher risk for reconstructive complications?

Alperovich M, Choi M, Frey JD, Lee ZH, Levine JP, Saadeh PB, Shapiro RL, Axelrod DM, Guth AA, Karp NS.

Plast Reconstr Surg. 2014 Aug;134(2):202e-206e. doi: 10.1097/PRS.0000000000000321.

PMID:
25068341
18.

Prone breast intensity modulated radiation therapy: 5-year results.

Osa EO, DeWyngaert K, Roses D, Speyer J, Guth A, Axelrod D, Fenton Kerimian M, Goldberg JD, Formenti SC.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):899-906. doi: 10.1016/j.ijrobp.2014.03.036. Epub 2014 May 24.

19.

Proactive approach to lymphedema risk reduction: a prospective study.

Fu MR, Axelrod D, Guth AA, Cartwright F, Qiu Z, Goldberg JD, Kim J, Scagliola J, Kleinman R, Haber J.

Ann Surg Oncol. 2014 Oct;21(11):3481-9. doi: 10.1245/s10434-014-3761-z. Epub 2014 May 9.

20.

Screening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same.

Friedman EB, Chun J, Schnabel F, Schwartz S, Law S, Billig J, Ivanoff E, Moy L, Axelrod D, Guth A.

Int J Breast Cancer. 2013;2013:327567. doi: 10.1155/2013/327567. Epub 2013 Sep 18.

Supplemental Content

Loading ...
Support Center